Related Experiment Video
Updated: Dec 9, 2025

06:39
Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
Published on: October 3, 2018
10.0K
Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor
Justin Taylor1,2, Mark Ta Donoghue3, Caleb Ho4
1Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
The Journal of Clinical Investigation
|September 8, 2020
Summary
Germ cell tumors (GCTs) and blood cancers in some patients share a common origin. This research reveals a unique clinical syndrome where these cancers evolve from a single precursor cell.
Area of Science:
- Oncology
- Genetics
- Cancer Biology
Background:
- Germ cell tumors (GCTs) are common in young men, but mediastinal GCTs have poor outcomes.
- A subset of patients with mediastinal GCTs develop secondary hematologic malignancies.
- A clonal relationship between GCTs and these secondary blood cancers is suspected but not fully understood.
Purpose of the Study:
- To investigate the clonal evolution and genetic underpinnings of GCTs and associated hematologic malignancies.
- To determine the precise relationship between these distinct cancer types in affected individuals.
Main Methods:
- Analysis of tumor samples from 15 patients with GCTs and concurrent hematologic malignancies.
- Tracing clonal evolution and characterizing genetic alterations across all neoplasms.
- Comparative genomic analysis to distinguish origins from de novo cancers.
Main Results:
- GCTs and hematologic malignancies in these patients originate from a common ancestral precursor.
- The precursor cells frequently exhibit p53 and/or RAS pathway mutations.
- Secondary hematologic malignancies genetically resemble mediastinal GCTs more than typical blood cancers.
Conclusions:
- This scenario represents a distinct clinical syndrome, not simply co-occurring cancers.
- An ancestral precursor with specific genetic mutations drives the parallel evolution of GCTs and blood cancers.
- Understanding this unique pathway may inform future therapeutic strategies.
Related Concept Videos
Lineage Commitment
3.9K
Commitment is the process whereby stem cells:
3.9K
Production of Formed Elements
3.3K
Hemangioblasts are multipotent stem cells originating from the mesoderm. They give rise to hematopoietic stem cells (HSCs), which undergo hematopoiesis to produce all the formed elements of blood. This process is regulated by a complex network of hematopoietic growth factors, including transcription factors, growth factors, and cytokines. These factors stimulate the HSCs to divide and differentiate, though some HSCs remain undifferentiated to maintain a self-renewing pool.
Most HSCs commit to...
Most HSCs commit to...
3.3K
Hematopoiesis
7.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
7.9K
Multipotency of Hematopoietic Stem Cells
3.6K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.6K
Differentiation of Common Myeloid Progenitor Cells
3.7K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.7K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K

